Contents Menu

Matsumoto Hiroaki

Affiliate Master Yamaguchi University

An invited review following the Soujinkai Fujiu Memorial Award : elucidation of drug resistance mechanisms in prostate cancer: overcome them by investigating bench to bedside

The bulletin of the Yamaguchi Medical School Volume 69 Issue 1-2 Page 1-9
published_at 2022-06
A050069000101
2.2 MB
Title
An invited review following the Soujinkai Fujiu Memorial Award : elucidation of drug resistance mechanisms in prostate cancer: overcome them by investigating bench to bedside
Abstract
Androgen receptor (AR)-signaling plays an important role in promoting tumor cell survival and the development of castration-resistant prostate cancer (CRPC). Androgen deprivation therapy is the basic therapeutic strategy for AR signaling blockade, but that effects wonʼt last long and most of metastatic prostate cancer show castration resistance. Recently, new agents, AR Axis Targeted agents (ARAT), have been developed. We have been developing our bench-to-bedside translational research to elucidate the mechanisms of drug resistance in prostate cancer. This review describes our investigational results and recent advances in CRPC with ARAT treatment strategy.
Creators Matsumoto Hiroaki
Affiliate Master Yamaguchi University
[kakenhi]15501 grid.268397.1
Creators Matsuyama Hideyasu
Affiliate Master Yamaguchi University
[kakenhi]15501 grid.268397.1
Source Identifiers [PISSN] 0513-1812 [EISSN] 2436-696X
Creator Keywords
castration-resistant prostate cancer androgen receptor clusterin castrationsensitive prostate cancer AR axis targeted agent
Languages eng
Resource Type departmental bulletin paper
Publishers Yamaguchi University School of Medicine
Date Issued 2022-06
File Version Version of Record
Access Rights open access
Schools 大学院医学系研究科(医学)